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Introduction
The lymphatic system serves as the primary route for the
metastasis of many cancers and the extent of lymphangio-
genesis involvement is the most important indicator of
tumor aggressiveness. Despite the apparent importance of
the lymphatic vessels for tumor dissemination, it has
remained unclear whether immune cells and lymphatic
endothelial cells interactions may affect tumor progression
and metastasis. Recent evidences indicate regulation of
lymph node lymphangiogenesis by T lymphocytes. How-
ever, the nature of the T cells involved and the nature of
the immune response in inflammatory lymph node lym-
phangiogenesis are still unveiled. We therefore charac-
terized the nature of the inflammatory response in
inflammatory lymph node lymphangiogenesis.
Methods
We used a mouse model of inflammatory lymph node
lymphangiogenesis and analyzed the nature of the immune
response mounted during lymph node lymphangiogenesis
and its role in regulating this pathophysiological process
using a combination of flow cytometry, immunohisto-
chemistry, cytokine analysis, and RT-PCR.
Results
Inflammatory lymph node lymphangiogenesis is a multi
step process defined by initiation, expansion and a return
to quiescence. We found that each step is tightly orche-
strated by a specific T cell response. At steady state
lymph node lymphangiogenesis is negatively regulated by
the anti lymphangiogenic cytokine IFNg, produced by
CD8a T cells. Initiation of inflammatory lymph node
lymphangiogenesis results in suppression of CD8a
producing IFNg T cells and of Th17 cells, and in expan-
sion of Th1 and Th2 cells. Furthermore, inflammatory
lymph node lymphangiogenesis is increased in mice
deficient in CD4 or CD8 T cells, suggesting a regulating
role for each of the T cell subtypes. The effect of the
T cell on inflammatory lymph node lymphangiogensis is
exerted by regulating the production of prolymphangio-
genic cytokines.
Conclusion
Our data suggest that lymphangiogenesis can be targeted
therapeutically at different stages, and by different way.
This can be a novel strategy to control tumor spread.
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